Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1371/journal.pone.0106082

http://scihub22266oqcxt.onion/10.1371/journal.pone.0106082
suck pdf from google scholar
25171482!4149463!25171482
unlimited free pdf from europmc25171482    free
PDF from PMC    free
html from PMC    free

Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=25171482&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215

suck abstract from ncbi

pmid25171482      PLoS+One 2014 ; 9 (8): e106082
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Oxymatrine improves intestinal epithelial barrier function involving NF-kappaB-mediated signaling pathway in CCl4-induced cirrhotic rats #MMPMID25171482
  • Wen JB; Zhu FQ; Chen WG; Jiang LP; Chen J; Hu ZP; Huang YJ; Zhou ZW; Wang GL; Lin H; Zhou SF
  • PLoS One 2014[]; 9 (8): e106082 PMID25171482show ga
  • Accumulating evidence suggests that intestinal epithelial barrier dysfunction plays an important role in the pathogenesis of hepatic cirrhosis and its complications such as gastrointestinal injury and hepatic encephalopathy. To date, there is no cure for cirrhosis-associated intestinal mucosal lesion and ulcer. This study aimed to investigate the effect of oxymatrine on intestinal epithelial barrier function and the underlying mechanism in carbon tetrachloride (CCl4)-induced cirrhotic rats. Thirty CCl4-induced cirrhotic rats were randomly divided into treatment group, which received oxymatrine treatment (63 mg/kg), and non-treatment group, which received the same dose of 5% glucose solution (vehicle). The blank group (n = 10 healthy rats) received no treatment. Terminal ileal samples were collected for histopathological examination. The expression level of nuclear factor-kappaB (NF-kappaB) p65 in ileal tissue was evaluated by immunohistochemistry. The gene and protein expression levels of tumor necrosis factor-alpha (TNF-alpha) and interleukin 6 (IL-6) in ileal tissues were analyzed by reverse-transcriptase polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA), respectively. Additionally, plasma endotoxin level was determined. In comparison to the blank group, a significant alteration in the morphology of intestinal mucosal villi in the non-treatment group was observed. The intestinal mucosal villi were atrophic, shorter, and fractured, and inflammatory cells were infiltrated into the lamina propria and muscular layer. Besides, serious swell of villi and loose structure of mucous membrane were observed. Oxymatrine reversed the CCl4-induced histological changes and restored intestinal barrier integrity. Moreover, oxymatrine reduced the protein expression level of NF-kappaB p65, TNF-alpha, and IL-6, which were elevated in the vehicle-treated group. In addition, the serum endotoxin level was significantly decreased after oxymatrine treatment in CCl4-induced cirrhotic rats. The results indicate that oxymatrine improves intestinal barrier function via NF-kappaB-mediated signaling pathway and may be used as a new protecting agent for cirrhosis-associated intestinal mucosal damage.
  • |Alkaloids/*pharmacology[MESH]
  • |Animals[MESH]
  • |Carbon Tetrachloride[MESH]
  • |Endotoxins/antagonists & inhibitors/blood[MESH]
  • |Enzyme-Linked Immunosorbent Assay[MESH]
  • |Gene Expression/drug effects[MESH]
  • |Immunohistochemistry[MESH]
  • |Interleukin-6/genetics/metabolism[MESH]
  • |Intestinal Mucosa/*drug effects/metabolism/physiopathology[MESH]
  • |Intestines/drug effects/pathology/physiopathology[MESH]
  • |Liver Cirrhosis/chemically induced/metabolism/*physiopathology[MESH]
  • |Male[MESH]
  • |Protective Agents/pharmacology[MESH]
  • |Quinolizines/*pharmacology[MESH]
  • |Random Allocation[MESH]
  • |Rats, Sprague-Dawley[MESH]
  • |Reverse Transcriptase Polymerase Chain Reaction[MESH]
  • |Signal Transduction/*drug effects[MESH]
  • |Transcription Factor RelA/*metabolism[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box